G. H. B. Nardotto

No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients

O. Della Pasqua, V. Bollela, G. H. B. Nardotto, 2021, Clinical and translational science.

Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type‐2 diabetes patients

O. Della Pasqua, G. H. B. Nardotto, V. Lanchote, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Population pharmacokinetics of carvedilol enantiomers and their metabolites in type-2 diabetes and healthy subjects

Pasqua, G. H. B. Nardotto, V. Lanchote, 2017 .

Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse–Berenice-78 Trypanosoma cruzi Strain Model

C. Carneiro, L. Perin, L. Pinto, 2020, Antimicrobial Agents and Chemotherapy.

Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic study.

G. H. B. Nardotto, V. Lanchote, E. Coelho, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism

C. Paiva, G. H. B. Nardotto, V. Lanchote, 2017, Journal of clinical pharmacology.

Systemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of Atorvastatin

E. Donadi, G. H. B. Nardotto, A. Rocha, 2020, Clinical and translational science.